In the present study, our data clearly showed that Mdivi-1 treatment inhibited cell proliferation of HCC cells both in vitro and in vivo, which was consist with the effect of Drp1 knockdown. The gene discussed is DNM1L; the disease is hepatocellular carcinoma.